[Form 4] IonQ, Inc. Insider Trading Activity
IonQ director Raymond John W received 3,063 restricted stock units (RSUs) on 09/25/2025 as reported on a Form 4. The RSUs were granted with no cash purchase price and are scheduled to vest in full on the earlier of the company’s 2026 Annual Meeting (or immediately prior if the reporting person’s directorship ends at that meeting) or June 18, 2026, provided the director remains in service through the vesting date. After this award the reporting person beneficially owns 3,063 shares directly. The filing was signed by an attorney-in-fact on 09/29/2025.
- Time-based RSU grant aligns director incentives with shareholders by requiring continued service through the vesting date
- Clear vesting schedule (earlier of 2026 Annual Meeting or June 18, 2026) reduces ambiguity about when shares convert
- Form 4 filed with attorney-in-fact signature within days of the transaction, indicating timely reporting
- None.
Insights
TL;DR: Director received time-based RSUs that align compensation with continued board service through mid-2026.
The grant of 3,063 RSUs to a director is a routine, time-vested equity award intended to align the director’s incentives with shareholder interests. The award vests on the earlier of the 2026 Annual Meeting or June 18, 2026, contingent on continued service, which is typical for non-employee directors. The award was granted at no cash cost to the director and increases the director’s direct beneficial ownership by 3,063 shares, a small position relative to a public company but meaningful for director alignment. No derivative transactions or exercises were reported.
TL;DR: Filing discloses a standard Section 16 reportable award with clear vesting conditions and timely filing.
The Form 4 reports acquisition code "A" for 3,063 RSUs with a price of $0, consistent with compensation awards. Vesting conditions are explicitly stated and tied to service through a defined date or corporate event, which reduces ambiguity for compliance purposes. The report identifies the reporting person as a director and shows a single reporting person filing. The form includes an attorney-in-fact signature and the report date, meeting reporting formalities. No material compliance issues are evident from the disclosed information.